Evidence map›Paper›PMID 36338889›Full record

ReviewWorld journal of gastroenterology2022

Pitfalls and promises of bile duct alternatives: A narrative review.

Mitsuo Miyazawa, Masayasu Aikawa, Junpei Takashima, Hirotoshi Kobayashi, Shunsuke Ohnishi, Yoshito Ikada

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Mitsuo MiyazawaDepartment of Surgery, Teikyo University Mizonokuch Hospital, Kanagawa 213-8507, Japan. mmiyazawa@med.teikyo-u.ac.jp.
Masayasu AikawaDepartment of Surgery, Saitama Medical University International Medical Center, Saitama 350-1298, Japan.
Junpei TakashimaDepartment of Surgery, Teikyo University Mizonokuch Hospital, Kanagawa 213-8507, Japan.
Hirotoshi KobayashiDepartment of Surgery, Teikyo University Mizonokuch Hospital, Kanagawa 213-8507, Japan.
Shunsuke OhnishiDepartment of Gastroenterology and Hepatology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo 060-8638, Japan.
Yoshito IkadaDepartment of Bioenvironmental Medicine, Nara Medical University, Nara 634-8521, Japan.
Teikyo University Hospital · JPHokkaido University · JPNara Medical University · JPSaitama International Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biliodigestive anastomosis between the extrahepatic bile duct and the intestine for bile duct disease is a gastrointestinal reconstruction that abolishes duodenal papilla function and frequently causes retrograde cholangitis. This chronic inflammation can cause liver dysfunction, liver abscess, and even bile duct cancer. Although research has been conducted for over 100 years to directly repair bile duct defects with alternatives, no bile duct substitute (BDS) has been developed. This narrative review confirms our understanding of why bile duct alternatives have not been developed and explains the clinical applicability of BDSs in the near future. We searched the PubMed electronic database to identify studies conducted to develop BDSs until December 2021 and identified studies in English. Two independent reviewers reviewed studies on large animals with 8 or more cases. Four types of BDSs prevail: Autologous tissue, non-bioabsorbable material, bioabsorbable material, and others (decellularized tissue, 3D-printed structures,

Indexed as

Bile Duct DiseasesBile Ducts, ExtrahepaticCholangitisAnastomosis, SurgicalAnimalsBile DuctsConstriction, PathologicBile duct alternativeBile duct reconstructionBile duct substituteBiliary regenerationBioabsorbable polymerPeribiliary gland

Identifiers

PMID36338889
PMCPMC9627420
OpenAlexW4306654043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.